Skip to content

Advantages of Transcutanous Electric Acupoint Stimulation plus Three-step Analgesic Ladder Treatment for the Moderate to Severe Cancer Pain Based on Analgesia and Immunoregulation

Advantage and Analgesic Efficacy Evaluation on Transcutanous Electric Acupoint Stimulation plus Three-step Analgesic Ladder Treatment for the Moderate to Severe Cancer Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003803
Enrollment
Unknown
Registered
2013-08-27
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to Severe Cancer Pain

Interventions

treatment group:Transcutanous Electric Acupoint Stimulation plus Three-step Analgesic Ladder Treatment
control group:Three-step Analgesic Ladder Treatment

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The age ranged 18-80 years old, both male and female; Life expectancy is more than 1 month; The patients with the cancer according to the criteria and Number Rating Scale(NRS)>=4, or equivalent morphine in 24h >=20mg; Clear mind, stable vital signs, KPS>=60; No intelligence and mental disorders, language expression ability is normal and cooperation to complete the assessment; Write informed consent file.

Exclusion criteria

Exclusion criteria: Pain is none business to cancer; Surgery within last 30 days, or with 89Sr or 53Sm treatment within last 3 months; Mental disease or severe cognitive impairment; Respiratory depression; Activity cerebrovascular disease; Opioid drug allergy; Skin lesions around acupoints; Patients participated in other clinical trials which affect this trail.

Design outcomes

Primary

MeasureTime frame
Pain;Life quality;immune function;

Secondary

MeasureTime frame
Safety evaluation;Compliance evaluatio;

Countries

China

Contacts

Public ContactYi Liang

The Third Affiliated Hospital of Zhejiang Chinese Medicine University

liangyiwww@126.com+86 13136171416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026